Brittany Bransford, APRN
Nurse Practitioner · Coeur D Alene, IDNPI 1265990774
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,945 of the $3,182 with a category attached, or 61.1%. Axonics, Inc. accounts for 61.8% of it on its own, with 12 other manufacturers making up the rest. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $48.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Sumitomo Pharma America, Inc.$302
- Johnson & Johnson$288
- Dendreon Pharmaceuticals LLC$236
- Medtronic$106
- AbbVie$79
- plus $203 from 7 others
What the payments were for
- Travel & lodging$1,23639%
- Food & beverage$1,94561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 25 | $1,967 |
| Sumitomo Pharma America, Inc. | 11 | $302 |
| Johnson & Johnson | 10 | $288 |
| Dendreon Pharmaceuticals LLC | 6 | $236 |
| Medtronic | 1 | $106 |
| AbbVie | 4 | $79 |
| Progenics Pharmaceuticals, Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $45 |
| Verity Pharmaceuticals Inc. | 1 | $34 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Immunitybio, Inc. | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,182 in reported general payments places this provider in the 90th percentile of 570 nurse practitioner providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 115 | $80,499 |
| GemtesaVibegron | 63 | $46,582 |
| Trospium Chloride | 55 | $3,391 |
| Potassium Citrate ErPotassium Citrate | 21 | $2,328 |
| Solifenacin Succinate | 47 | $1,783 |
| Tolterodine Tartrate ErTolterodine Tartrate | 13 | $1,610 |
| Tamsulosin Hcl | 142 | $1,541 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $1,112 |
| Trimethoprim | 13 | $1,106 |
| Oxybutynin Chloride ErOxybutynin Chloride | 46 | $1,042 |
| Testosterone Cypionate | 46 | $1,033 |
| Finasteride | 46 | $747 |
| Oxybutynin Chloride | 40 | $694 |
| Estradiol | 11 | $683 |
| Desmopressin Acetate | 13 | $330 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $45 | $80,499115 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $302 | $46,58263 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 570 nurse practitioner providers in Idaho.
Other nurse practitioner in Coeur D Alene
- Alissa HelvikCoeur D Alene$93K
- Jamie TeskyCoeur D Alene$7K
- Ashley StroudCoeur D Alene$7K
- Lindsey AnagnostopoulosCoeur D Alene$7K
- Jennifer TorokCoeur D Alene$4K
- Shana MayCoeur D Alene$4K
- Krista TickemyerCoeur D Alene$4K
- Karla HansenCoeur D Alene$3K
- Laura HaneyCoeur D Alene$3K
- Amanda WoodCoeur D Alene$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.